For example, DSA has been used to construct an ADC, Promiximab-DUBA (an anti-CD56 monoclonal antibody conjugated to duocarmycin), for the treatment of small cell lung cancer (SCLC) [56]. Here, NCAM1 is linked to small cell lung carcinoma.